MEMPHIS, Tenn. (AP) — The Merck & Co. manufacturing site in Memphis has survived a round of plant closings.
The pharmaceutical company is closing eight manufacturing sites and eight research sites to streamline operations following its merger with Schering-Plough last November. With the merger, Merck acquired the Memphis-based consumer health products division of Schering-Plough Corp.
The division based in Memphis is not involved with prescription drugs. It does have several global brands, including Claritin, Coppertone and Dr. Scholl’s, which are manufactured and distributed from Memphis.
According to The Memphis Daily News, a Merck spokesman said he could not provide any information about future plans for the Memphis operation.